カテゴリー： Market Monitor Global, 世界, 医療/バイオ

麻疹・風疹（MR）ワクチンの世界市場見通し2023年-2029年

◆英語タイトル：Measles and Rubella (MR) Vaccine Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5739）◆商品コード：MMG23JU5739
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月（※2025年版があります。お問い合わせください。）
◆ページ数：79
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥468,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥608,400見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥702,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Measles and Rubella (MR) Vaccine Market 調査レポートは次の情報を含め、グローバルにおけるの麻疹・風疹（MR）ワクチン市場規模と予測を収録しています。・世界の麻疹・風疹（MR）ワクチン市場：売上、2018年-2023年、2024年-2029年
・世界の麻疹・風疹（MR）ワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の麻疹・風疹（MR）ワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「MRワクチン」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

麻疹・風疹（MR）ワクチンのグローバル主要企業は、PT Bio Farma、 Bio-Manguinhos、 BE Vaccines、 Crucell Switzerland AGなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、麻疹・風疹（MR）ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の麻疹・風疹（MR）ワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界の麻疹・風疹（MR）ワクチン市場：タイプ別市場シェア、2022年
・MRワクチン、MRBEVワクチン

世界の麻疹・風疹（MR）ワクチン市場：用途別、2018年-2023年、2024年-2029年
世界の麻疹・風疹（MR）ワクチン市場：用途別市場シェア、2022年
・プライベート流通チャネル、パブリック流通チャネル

世界の麻疹・風疹（MR）ワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界の麻疹・風疹（MR）ワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における麻疹・風疹（MR）ワクチンのグローバル売上、2018年-2023年
・主要企業における麻疹・風疹（MR）ワクチンのグローバル売上シェア、2022年
・主要企業における麻疹・風疹（MR）ワクチンのグローバル販売量、2018年-2023年
・主要企業における麻疹・風疹（MR）ワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
PT Bio Farma、 Bio-Manguinhos、 BE Vaccines、 Crucell Switzerland AG

*************************************************************

・調査・分析レポートの概要
麻疹・風疹（MR）ワクチン市場の定義
市場セグメント
世界の麻疹・風疹（MR）ワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の麻疹・風疹（MR）ワクチン市場規模
世界の麻疹・風疹（MR）ワクチン市場規模：2022年 VS 2029年
世界の麻疹・風疹（MR）ワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの麻疹・風疹（MR）ワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の麻疹・風疹（MR）ワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：MRワクチン、MRBEVワクチン
麻疹・風疹（MR）ワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：プライベート流通チャネル、パブリック流通チャネル
麻疹・風疹（MR）ワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別麻疹・風疹（MR）ワクチン市場規模 2022年と2029年
地域別麻疹・風疹（MR）ワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
PT Bio Farma、 Bio-Manguinhos、 BE Vaccines、 Crucell Switzerland AG
...

This report aims to provide a comprehensive presentation of the global market for Measles and Rubella (MR) Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Measles and Rubella (MR) Vaccine. This report contains market size and forecasts of Measles and Rubella (MR) Vaccine in global, including the following market information:
Global Measles and Rubella (MR) Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Measles and Rubella (MR) Vaccine Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Measles and Rubella (MR) Vaccine companies in 2022 (%)
The global Measles and Rubella (MR) Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
MR Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Measles and Rubella (MR) Vaccine include PT Bio Farma, Bio-Manguinhos, BE Vaccines and Crucell Switzerland AG, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Measles and Rubella (MR) Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Measles and Rubella (MR) Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Measles and Rubella (MR) Vaccine Market Segment Percentages, by Type, 2022 (%)
MR Vaccine
MRBEV Vaccine
Global Measles and Rubella (MR) Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Measles and Rubella (MR) Vaccine Market Segment Percentages, by Application, 2022 (%)
Private Distribution Channel
Public Distribution Channel
Global Measles and Rubella (MR) Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Measles and Rubella (MR) Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Measles and Rubella (MR) Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Measles and Rubella (MR) Vaccine revenues share in global market, 2022 (%)
Key companies Measles and Rubella (MR) Vaccine sales in global market, 2018-2023 (Estimated), (Units)
Key companies Measles and Rubella (MR) Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
PT Bio Farma
Bio-Manguinhos
BE Vaccines
Crucell Switzerland AG
Outline of Major Chapters:
Chapter 1: Introduces the definition of Measles and Rubella (MR) Vaccine, market overview.
Chapter 2: Global Measles and Rubella (MR) Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Measles and Rubella (MR) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Measles and Rubella (MR) Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Measles and Rubella (MR) Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Measles and Rubella (MR) Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Measles and Rubella (MR) Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Measles and Rubella (MR) Vaccine Overall Market Size
2.1 Global Measles and Rubella (MR) Vaccine Market Size: 2022 VS 2029
2.2 Global Measles and Rubella (MR) Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Measles and Rubella (MR) Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Measles and Rubella (MR) Vaccine Players in Global Market
3.2 Top Global Measles and Rubella (MR) Vaccine Companies Ranked by Revenue
3.3 Global Measles and Rubella (MR) Vaccine Revenue by Companies
3.4 Global Measles and Rubella (MR) Vaccine Sales by Companies
3.5 Global Measles and Rubella (MR) Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Measles and Rubella (MR) Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Measles and Rubella (MR) Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Measles and Rubella (MR) Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Measles and Rubella (MR) Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Measles and Rubella (MR) Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Measles and Rubella (MR) Vaccine Market Size Markets, 2022 & 2029
4.1.2 MR Vaccine
4.1.3 MRBEV Vaccine
4.2 By Type – Global Measles and Rubella (MR) Vaccine Revenue & Forecasts
4.2.1 By Type – Global Measles and Rubella (MR) Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Measles and Rubella (MR) Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Measles and Rubella (MR) Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Measles and Rubella (MR) Vaccine Sales & Forecasts
4.3.1 By Type – Global Measles and Rubella (MR) Vaccine Sales, 2018-2023
4.3.2 By Type – Global Measles and Rubella (MR) Vaccine Sales, 2024-2029
4.3.3 By Type – Global Measles and Rubella (MR) Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Measles and Rubella (MR) Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Measles and Rubella (MR) Vaccine Market Size, 2022 & 2029
5.1.2 Private Distribution Channel
5.1.3 Public Distribution Channel
5.2 By Application – Global Measles and Rubella (MR) Vaccine Revenue & Forecasts
5.2.1 By Application – Global Measles and Rubella (MR) Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Measles and Rubella (MR) Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Measles and Rubella (MR) Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Measles and Rubella (MR) Vaccine Sales & Forecasts
5.3.1 By Application – Global Measles and Rubella (MR) Vaccine Sales, 2018-2023
5.3.2 By Application – Global Measles and Rubella (MR) Vaccine Sales, 2024-2029
5.3.3 By Application – Global Measles and Rubella (MR) Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Measles and Rubella (MR) Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Measles and Rubella (MR) Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Measles and Rubella (MR) Vaccine Revenue & Forecasts
6.2.1 By Region – Global Measles and Rubella (MR) Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Measles and Rubella (MR) Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Measles and Rubella (MR) Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Measles and Rubella (MR) Vaccine Sales & Forecasts
6.3.1 By Region – Global Measles and Rubella (MR) Vaccine Sales, 2018-2023
6.3.2 By Region – Global Measles and Rubella (MR) Vaccine Sales, 2024-2029
6.3.3 By Region – Global Measles and Rubella (MR) Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Measles and Rubella (MR) Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Measles and Rubella (MR) Vaccine Sales, 2018-2029
6.4.3 US Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.4.4 Canada Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.4.5 Mexico Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Measles and Rubella (MR) Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Measles and Rubella (MR) Vaccine Sales, 2018-2029
6.5.3 Germany Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.5.4 France Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.5.5 U.K. Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.5.6 Italy Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.5.7 Russia Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.5.9 Benelux Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Measles and Rubella (MR) Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Measles and Rubella (MR) Vaccine Sales, 2018-2029
6.6.3 China Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.6.4 Japan Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.6.5 South Korea Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.6.7 India Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Measles and Rubella (MR) Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Measles and Rubella (MR) Vaccine Sales, 2018-2029
6.7.3 Brazil Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.7.4 Argentina Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Measles and Rubella (MR) Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Measles and Rubella (MR) Vaccine Sales, 2018-2029
6.8.3 Turkey Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.8.4 Israel Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.8.6 UAE Measles and Rubella (MR) Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 PT Bio Farma
7.1.1 PT Bio Farma Company Summary
7.1.2 PT Bio Farma Business Overview
7.1.3 PT Bio Farma Measles and Rubella (MR) Vaccine Major Product Offerings
7.1.4 PT Bio Farma Measles and Rubella (MR) Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 PT Bio Farma Key News & Latest Developments
7.2 Bio-Manguinhos
7.2.1 Bio-Manguinhos Company Summary
7.2.2 Bio-Manguinhos Business Overview
7.2.3 Bio-Manguinhos Measles and Rubella (MR) Vaccine Major Product Offerings
7.2.4 Bio-Manguinhos Measles and Rubella (MR) Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Bio-Manguinhos Key News & Latest Developments
7.3 BE Vaccines
7.3.1 BE Vaccines Company Summary
7.3.2 BE Vaccines Business Overview
7.3.3 BE Vaccines Measles and Rubella (MR) Vaccine Major Product Offerings
7.3.4 BE Vaccines Measles and Rubella (MR) Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 BE Vaccines Key News & Latest Developments
7.4 Crucell Switzerland AG
7.4.1 Crucell Switzerland AG Company Summary
7.4.2 Crucell Switzerland AG Business Overview
7.4.3 Crucell Switzerland AG Measles and Rubella (MR) Vaccine Major Product Offerings
7.4.4 Crucell Switzerland AG Measles and Rubella (MR) Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Crucell Switzerland AG Key News & Latest Developments
8 Global Measles and Rubella (MR) Vaccine Production Capacity, Analysis
8.1 Global Measles and Rubella (MR) Vaccine Production Capacity, 2018-2029
8.2 Measles and Rubella (MR) Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Measles and Rubella (MR) Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Measles and Rubella (MR) Vaccine Supply Chain Analysis
10.1 Measles and Rubella (MR) Vaccine Industry Value Chain
10.2 Measles and Rubella (MR) Vaccine Upstream Market
10.3 Measles and Rubella (MR) Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Measles and Rubella (MR) Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Measles and Rubella (MR) Vaccine in Global Market
Table 2. Top Measles and Rubella (MR) Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Measles and Rubella (MR) Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Measles and Rubella (MR) Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Measles and Rubella (MR) Vaccine Sales by Companies, (Units), 2018-2023
Table 6. Global Measles and Rubella (MR) Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Measles and Rubella (MR) Vaccine Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Measles and Rubella (MR) Vaccine Product Type
Table 9. List of Global Tier 1 Measles and Rubella (MR) Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Measles and Rubella (MR) Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Measles and Rubella (MR) Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Measles and Rubella (MR) Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Measles and Rubella (MR) Vaccine Sales (Units), 2018-2023
Table 15. By Type - Global Measles and Rubella (MR) Vaccine Sales (Units), 2024-2029
Table 16. By Application – Global Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Measles and Rubella (MR) Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Measles and Rubella (MR) Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Measles and Rubella (MR) Vaccine Sales (Units), 2018-2023
Table 20. By Application - Global Measles and Rubella (MR) Vaccine Sales (Units), 2024-2029
Table 21. By Region – Global Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Measles and Rubella (MR) Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Measles and Rubella (MR) Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Measles and Rubella (MR) Vaccine Sales (Units), 2018-2023
Table 25. By Region - Global Measles and Rubella (MR) Vaccine Sales (Units), 2024-2029
Table 26. By Country - North America Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Measles and Rubella (MR) Vaccine Sales, (Units), 2018-2023
Table 29. By Country - North America Measles and Rubella (MR) Vaccine Sales, (Units), 2024-2029
Table 30. By Country - Europe Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Measles and Rubella (MR) Vaccine Sales, (Units), 2018-2023
Table 33. By Country - Europe Measles and Rubella (MR) Vaccine Sales, (Units), 2024-2029
Table 34. By Region - Asia Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Measles and Rubella (MR) Vaccine Sales, (Units), 2018-2023
Table 37. By Region - Asia Measles and Rubella (MR) Vaccine Sales, (Units), 2024-2029
Table 38. By Country - South America Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Measles and Rubella (MR) Vaccine Sales, (Units), 2018-2023
Table 41. By Country - South America Measles and Rubella (MR) Vaccine Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Measles and Rubella (MR) Vaccine Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Measles and Rubella (MR) Vaccine Sales, (Units), 2024-2029
Table 46. PT Bio Farma Company Summary
Table 47. PT Bio Farma Measles and Rubella (MR) Vaccine Product Offerings
Table 48. PT Bio Farma Measles and Rubella (MR) Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. PT Bio Farma Key News & Latest Developments
Table 50. Bio-Manguinhos Company Summary
Table 51. Bio-Manguinhos Measles and Rubella (MR) Vaccine Product Offerings
Table 52. Bio-Manguinhos Measles and Rubella (MR) Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Bio-Manguinhos Key News & Latest Developments
Table 54. BE Vaccines Company Summary
Table 55. BE Vaccines Measles and Rubella (MR) Vaccine Product Offerings
Table 56. BE Vaccines Measles and Rubella (MR) Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. BE Vaccines Key News & Latest Developments
Table 58. Crucell Switzerland AG Company Summary
Table 59. Crucell Switzerland AG Measles and Rubella (MR) Vaccine Product Offerings
Table 60. Crucell Switzerland AG Measles and Rubella (MR) Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Crucell Switzerland AG Key News & Latest Developments
Table 62. Measles and Rubella (MR) Vaccine Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 63. Global Measles and Rubella (MR) Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 64. Global Measles and Rubella (MR) Vaccine Production by Region, 2018-2023 (Units)
Table 65. Global Measles and Rubella (MR) Vaccine Production by Region, 2024-2029 (Units)
Table 66. Measles and Rubella (MR) Vaccine Market Opportunities & Trends in Global Market
Table 67. Measles and Rubella (MR) Vaccine Market Drivers in Global Market
Table 68. Measles and Rubella (MR) Vaccine Market Restraints in Global Market
Table 69. Measles and Rubella (MR) Vaccine Raw Materials
Table 70. Measles and Rubella (MR) Vaccine Raw Materials Suppliers in Global Market
Table 71. Typical Measles and Rubella (MR) Vaccine Downstream
Table 72. Measles and Rubella (MR) Vaccine Downstream Clients in Global Market
Table 73. Measles and Rubella (MR) Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Measles and Rubella (MR) Vaccine Segment by Type in 2022
Figure 2. Measles and Rubella (MR) Vaccine Segment by Application in 2022
Figure 3. Global Measles and Rubella (MR) Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Measles and Rubella (MR) Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Measles and Rubella (MR) Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Measles and Rubella (MR) Vaccine Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Measles and Rubella (MR) Vaccine Revenue in 2022
Figure 9. By Type - Global Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Measles and Rubella (MR) Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Measles and Rubella (MR) Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Measles and Rubella (MR) Vaccine Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Measles and Rubella (MR) Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Measles and Rubella (MR) Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Measles and Rubella (MR) Vaccine Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Measles and Rubella (MR) Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Measles and Rubella (MR) Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Measles and Rubella (MR) Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Measles and Rubella (MR) Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Measles and Rubella (MR) Vaccine Sales Market Share, 2018-2029
Figure 23. US Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Measles and Rubella (MR) Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Measles and Rubella (MR) Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Measles and Rubella (MR) Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Measles and Rubella (MR) Vaccine Sales Market Share, 2018-2029
Figure 37. China Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Measles and Rubella (MR) Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Measles and Rubella (MR) Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Measles and Rubella (MR) Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Measles and Rubella (MR) Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Measles and Rubella (MR) Vaccine Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Measles and Rubella (MR) Vaccine by Region, 2022 VS 2029
Figure 54. Measles and Rubella (MR) Vaccine Industry Value Chain
Figure 55. Marketing Channels

※参考情報

麻疹・風疹（MR）ワクチンは、麻疹ウイルスと風疹ウイルスに対する免疫を獲得するためのワクチンです。このワクチンの接種は、特に子供にとって重要であり、これにより重篤な合併症を防ぎ、全体の公衆衛生を向上させる役割を果たしています。

麻疹は非常に感染力が強いウイルス性の病気で、発疹や発熱などを引き起こし、場合によっては肺炎や脳炎といった重篤な合併症を伴うことがあります。また、風疹も感染力は比較的高く、特に妊婦が感染すると胎児に重大な影響を及ぼすことがあります。風疹による先天性風疹症候群は、出生児に心疾患や白内障、聴覚障害などの障害を引き起こす可能性があるため、特に注意が必要です。このような背景を持つ麻疹・風疹ワクチンは、公衆衛生の観点からも非常に重要な役割を担っています。

MRワクチンは、主に生ワクチンとして開発されており、弱毒化された麻疹ウイルスおよび風疹ウイルスを含んでいます。この性質により、体内で感染に対する免疫を構築することができます。MRワクチンは通常、1歳から2歳の間に接種されることが推奨されており、これにより子供たちがそれぞれのウイルスに対する免疫を獲得します。加えて、特定の国や地域では、複数回の接種を通じてより強固な免疫を得ることが求められる場合もあります。

MRワクチンの特徴としては、高い安全性と効果が挙げられます。接種後に副作用が見られることもありますが、一般的には軽微であり、発熱や局所的な腫れなどが主なものです。重篤な副作用は非常に稀ですが、一部の人々にはアレルギー反応が出る可能性もあるため、接種時には注意が必要です。

MRワクチンは、特に公衆衛生上の取り組みにおいて重要な役割を果たしています。麻疹と風疹の流行を防ぐためには、集団免疫を獲得することが不可欠です。集団免疫とは、一定の割合の人々が免疫を持つことで、人口全体を守る仕組みです。これにより、免疫を持たない人々も間接的に守られることになります。そのため、MRワクチンの接種率を高めることが、病気の流行を抑制する鍵となります。

関連する技術としては、ワクチンの生産技術や接種方法があります。麻疹・風疹ワクチンの製造には、ウイルスの培養が不可欠です。ウイルスを細胞培養し、弱毒化を行う過程で、ワクチンとして安全性が確認されたものだけが市場に提供されます。また、接種方法についても、通常は筋肉内接種が行われますが、今後は自己接種可能なデバイスなどの開発も期待されています。

世界的に見ても、麻疹・風疹ワクチンの普及は顕著であり、多くの国々が定期接種プログラムに組み込んでいます。特に国際連合や世界保健機関（WHO）などの国際機関は、ワクチン接種の重要性を広く訴え、全世界の人口に対する接種率の向上を目指したキャンペーンを行っています。これにより、多くの国で麻疹や風疹の発生が大幅に削減されています。

日本においても、MRワクチンの接種は定期接種として位置付けられており、厚生労働省のガイドラインに沿って実施されています。地域によっては、接種を促進するための様々な施策が講じられています。これには、接種の無料化や啓発活動が含まれ、子供たちが適切な時期にワクチンを受けられるように配慮されています。

しかし、近年ではワクチンに対する誤解や疑念が生じることもあります。そのため、医療従事者や公衆衛生の専門家は、正しい情報の提供や啓発活動を通じて、ワクチン接種の重要性を根付かせるための努力を続けています。このような活動が、子供たちや今後の世代の健康を守るための鍵となるでしょう。

麻疹・風疹ワクチンの効果は科学的にも証明されており、ワクチン接種によって感染症の発生率が劇的に低下していることが報告されています。この成功事例は、他の感染症に対するワクチン接種の必要性を再認識させる要因となっています。将来的には、新しい技術を用いたワクチンの開発が進行し、さらなる効果的な感染症対策が期待されます。

総じて、麻疹・風疹（MR）ワクチンは、個々の健康を守るだけでなく、地域社会や世界全体の公衆衛生を向上させるために不可欠な手段です。安全で効果的なワクチンの普及と、正確な情報提供が今後の課題であり、私たち一人一人がこの問題に対して理解を深め、積極的に関与することが求められています。


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 麻疹・風疹（MR）ワクチンの世界市場見通し2023年-2029年(Measles and Rubella (MR) Vaccine Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 麻疹・おたふく風邪・風疹ウイルスワクチンの世界市場見通し2023年-2029年
  • 麻疹ワクチンの世界市場見通し2023年-2029年
  • ジフテリア/破傷風/百日咳（DPT）ワクチンの世界市場見通し2023年-2029年
  • 豚生殖呼吸器症候群（PRRS）ワクチンの世界市場見通し2023年-2029年
  • 麻疹弱毒生ワクチンのグローバル市場2025年：企業・地域・タイプ・用途別分析

    • ◆H&Iグローバルリサーチのお客様（例）◆